Unknown NA INTERVENTIONAL 1-arm NCT02324101

Clinical Trial of Quantitative Detection Kit for Hsp90α in Breast Cancer

Sponsor: Protgen Ltd

Interventions Hsp90

Updated 6 times since 2017 Last updated: Dec 22, 2014 Started: Apr 30, 2013 Primary completion: Dec 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Breast Cancer, this trial is ongoing. The trial is conducted by Protgen Ltd and has accumulated 6 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Feb 2017 — Jun 2018 [monthly]

Unknown Status NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status NA

First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Protgen Ltd

Data source: Protgen Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tianjin, China